PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.76
2 yrs 8 m
0%
926.55 Crs
NIL
Large Growth
9.58
SIP 100 & Lumpsum 500
BSE HEALTH CARE - TRI
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk